RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. FCF margin (%)

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$28.4B
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 20244.5-14.80%
Dec 31, 20235.3-23.89%
Dec 31, 20227+369.72%
Dec 31, 20211.5-61.19%
Dec 31, 20203.8+190.01%
Dec 31, 20191.3-86.13%
Dec 31, 20189.5-19.06%
Dec 31, 201711.8-40.42%
Dec 31, 201619.7-18.67%
Dec 31, 201524.3+17.21%
Dec 31, 201420.7+90.69%
Dec 31, 201310.9-36.38%
Dec 31, 201217.1+1.45%
Dec 31, 201116.8-20.83%
Dec 31, 201021.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)